Table 1.
Variable | Mean ± SD (n, %) |
---|---|
No. of patients | 41 |
Age (years) | 53.95 ± 14.10 |
Gender (male) | 13 (31.7 %) |
Size of tumor (mm) | 16.34 ± 5.89 |
Location of tumor | |
Antrum anterior wall | 1 (2.44 %) |
Antrum greater curvature | 2 (4.88 %) |
Corpus anterior wall | 6 (14.63 %) |
Corpus greater curvature | 6 (14.63 %) |
Corpus lesser curvature | 4 (9.76 %) |
Corpus posterior wall | 9 (21.95 %) |
Fundus | 13 (31.71 %) |
Duration of EFTR | 78.82 ± 46.44 |
OTSC | 6 (14.63 %) |
Pneumoperitonea during EFTR | 26 (63.41 %) |
Cost of defect closing | 1014.04 ± 524.89 |
In-hospital days | 5.39 ± 1.14 |
Pathology | |
Carcinoid tumor | 1 (2.44 %) |
GIST | 33 (80.49 %) |
Heterotopic pancreas | 1 (2.44 %) |
Hyaline degeneration | 1 (2.44 %) |
Leiomyoma | 4 (9.76) |
Schwannoma | 1 (2.44 %) |
Complications | 9 (21.95 %) |
Abdominal pain | 2 (4.88 %) |
Dysuresia | 1 (2.44 %) |
Abdominal pain and fever | 3 (7.32 %) |
Nausea and vomiting | 1 (2.44 %) |
Pharyngalgia | 1 (2.44 %) |
Tenderness of upper abdomen | 1 (2.44 %) |
OTSC over-the-scope clip system, GIST gastrointestinal stromal tumor